Form 4 Tracker
Ryan Cohlhepp

Director, President and COO · 7 filings · Latest: Apr 15, 2026

Bicara Therapeutics Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
BCAX
Ryan CohlheppDirector, President and COOApr 15, 2026
Sale
$23.0112,500$287.6K196,141
BCAX
Ryan CohlheppDirector, President and COOApr 15, 2026
Option Exercise
$3.798,000$30.3K208,641
BCAX
Cohlhepp RyanApr 15, 2026
Proposed Sale
$22.9812,500$287.3K
BCAX
Ryan CohlheppDirector, President and COOMar 16, 2026
Sale
$19.6612,500$245.7K200,641
BCAX
Ryan CohlheppDirector, President and COOMar 16, 2026
Option Exercise
$3.798,000$30.3K213,141
BCAX
Cohlhepp RyanMar 16, 2026
Proposed Sale
$19.3412,500$241.8K
BCAX
Ryan CohlheppDirector, President and COOMar 3, 2026
Sale
$18.1617,392$315.9K205,141
BCAX
Ryan CohlheppDirector, President and COOMar 3, 2026
Option Exercise
$3.7912,892$48.9K222,533
BCAX
Cohlhepp RyanMar 3, 2026
Proposed Sale
$18.1617,392$315.9K
BCAX
Ryan CohlheppDirector, President and COOFeb 25, 2026
Sale
$18.043,631$65.5K209,641
BCAX
Ryan CohlheppDirector, President and COOFeb 25, 2026
Option Exercise
$3.793,108$11.8K213,272
BCAX
Cohlhepp RyanFeb 25, 2026
Proposed Sale
$18.043,631$65.5K
BCAX
Ryan CohlheppDirector, President and COOJan 22, 2026
Sale
$18.103,828$69.3K210,164
BCAX
Cohlhepp RyanJan 22, 2026
Proposed Sale
$16.973,828$65.0K
BCAX
Ryan CohlheppDirector, President and COOJan 15, 2026
Sale
$18.02149$2.7K213,992
BCAX
Cohlhepp RyanJan 15, 2026
Proposed Sale
$18.02149$2.7K
BCAX
Cohlhepp RyanDec 15, 2025
Proposed Sale
$18.7012,500$233.8K
BCAX
Cohlhepp RyanNov 21, 2025
Proposed Sale
$18.0512,500$225.6K
BCAX
Cohlhepp RyanOct 15, 2025
Proposed Sale
$18.1312,500$226.6K
BCAX
Cohlhepp RyanOct 7, 2025
Proposed Sale
$18.0010,900$196.2K

Page 1 of 2

Next →